This bill prohibits the $0.50 surcharge on rideshare trips that are designated for paratransit service, which includes transportation for people with disabilities and Medicaid non-emergency medical transport. It directly affects users of apps like Uber and Lyft who rely on these services for accessibility needs, ensuring they are not charged the extra fee required for regular prearranged rides. The legislation also clarifies that transportation network companies are not personally liable for these specific paratransit trips. By amending existing state laws, the bill removes the financial barrier for eligible riders while maintaining the surcharge for standard rides.
This bill expands the definition of Health Care Service Firms in New Jersey to include any agency that refers individuals to provide companion, health care, or personal care services in the homes of people with disabilities or those aged 60 and older. Under the new rules, these firms must register with the Division of Consumer Affairs and obtain accreditation from a recognized body within 12 months of registration. Additionally, the legislation requires larger firms to submit annual financial statements and periodic audits or third-party reports based on their revenue and Medicaid funding levels. These changes aim to increase oversight and transparency for a broader range of organizations serving elderly and disabled residents.
This bill requires New Jersey Medicaid managed care organizations to prioritize lower-cost generic and biosimilar drugs over their brand-name counterparts. Specifically, it mandates that patients prescribed a brand drug for the first time receive a biosimilar if one is available, unless a healthcare provider appeals this decision. Additionally, the law forces insurers to place cheaper generics and biosimilars on their drug formularies with better pricing and fewer access restrictions, such as prior authorizations, whenever these alternatives are less expensive than the original products. The bill also improves transparency by requiring these organizations to publish their drug lists online in an easy-to-find format that does not require users to create an account.
This New Jersey Assembly resolution urges the federal government to pass a bill that would remove waiting periods for disability benefits and Medicare for people with young-onset Alzheimer's diagnosed before age 65. The proposed federal law aims to eliminate the current 29-month delay in Medicaid coverage, ensuring these individuals receive medical support immediately upon diagnosis. By addressing bureaucratic delays, the legislation seeks to provide timely access to care for approximately 200,000 Americans affected by the disease and their families.
This bill requires NJ FamilyCare to cover prescriptions for healthy foods for certain enrollees, aiming to improve nutrition access for people with diet-related health conditions. It defines a "food prescription" as a healthcare provider's written order for specific foods to treat conditions like obesity or diabetes. The legislation also establishes a fund and program to support small food retailers and pharmacies in low and moderate-income areas to stock and sell fresh produce and other healthy items at affordable prices. By integrating healthy food prescriptions into the state's Medicaid program, the bill seeks to help residents in underserved communities gain better access to nutritious options.
This bill creates a statewide "Zero Suicide" initiative within New Jersey's Department of Health to help healthcare facilities and behavioral health providers prevent suicide through evidence-based practices. The program will offer voluntary training, technical assistance, and certification for organizations that adopt specific safety protocols, such as risk screening and continuity of care plans. To support these efforts, the legislation allows for grants to certified providers and establishes a framework for enhanced Medicaid reimbursement incentives. Ultimately, the act aims to integrate suicide prevention into routine clinical care while recognizing and rewarding facilities that successfully implement these standards.
This bill creates the Oral Health Equity Act to expand access to dental care for uninsured and underinsured residents in New Jersey's medically underserved areas. It directs the Department of Human Services to partner with specific community health centers to provide a package of services, including comprehensive exams, restorative treatment, and two annual visits per patient. To support these efforts, the bill mandates that the state reimburse participating centers at rates equal to or higher than those paid to federally qualified health centers. Additionally, the legislation requires the state to seek necessary Medicaid waivers to secure federal funding for these new programs.
This bill establishes the Mom Project oral health program within New Jersey's Department of Health to provide dental care to low-income pregnant women and new mothers. The legislation defines eligible participants as residents enrolled in Medicaid or NJ FamilyCare and allocates $3 million in funding to support the initiative. The program specifically targets medically underserved areas to address barriers such as lack of insurance, language differences, and discrimination that often prevent these women from accessing necessary dental services. By connecting eligible mothers with community oral health centers and dental homes, the bill aims to treat periodontal disease and reduce risks associated with preterm birth and low birth weight.
This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.
This New Jersey bill mandates that all health insurance plans and Medicaid programs cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law requires these benefits to be treated the same as coverage for other conditions, specifically exempting them from step therapy requirements that often delay access to medications. These provisions apply to hospital, medical, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. The coverage must be determined by a physician and align with the official labeling approved by the U.S. Food and Drug Administration.
